Financials
- Market Capitalization 1.52 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.08
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2167 | LBRX LB Pharmaceuticals Inc - Common Stock | 48.50 USD | +1.27% | +2.39% | +38.02% | +155.26% | 1.56 B USD | ||
| 2175 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.47 USD | -1.51% | -2.64% | +2.92% | +7.08% | 1.54 B USD | ||
| 2187 | INVA Innoviva, Inc. - Common Stock | 20.92 USD | -0.19% | -1.27% | -3.86% | +17.40% | 1.51 B USD | ||
| 2188 | ABSI Absci Corporation - Common Stock | 8.78 USD | -6.79% | -9.58% | +24.01% | +255.47% | 1.51 B USD |